Published in Cancer Weekly, July 12th, 1999
Hemangiomas are the most frequent tumors of infancy. The pathogenesis of these tumors is not well understood, and current treatment of juvenile hemangiomas remains unsatisfactory.
Sandra Liekens and colleagues of Belgium's Rega Institute for Medical Research, University Hospitals, reported on a novel animal model to study proliferating hemangiomas and to evaluate the effect of angiostatic compounds on their growth ("A Novel Animal Model for Hemangiomas: Inhibition of Hemangioma Development by the Angiogenesis Inhibitor TNP-470," Cancer Res,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.